Hester Biosciences announced the appointment of Ashish Desai as Chief Financial Officer and Key Managerial Personnel of the Company (categorised as Senior Management Personnel), presently serving as Group Finance Controller will assume the role of Chief Financial Officer of the Company with effect from 20 November 2025.Powered by Capital Market - Live News

Net profit of Hester Biosciences rose 76.22% to Rs 14.45 crore in the quarter ended September 2025 as against Rs 8.20 crore during the previous quarter ended September 2024. Sales declined 15.20% to Rs 70.97 crore in the quarter ended September 2025 as against Rs 83.69 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales70.9783.69 -15 OPM %16.5122.89 - PBDT21.3916.07 33 PBT17.0411.87 44 NP14.458.20 76 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Net profit of Hester Biosciences rose 159.31% to Rs 16.44 crore in the quarter ended June 2025 as against Rs 6.34 crore during the previous quarter ended June 2024. Sales rose 2.24% to Rs 84.11 crore in the quarter ended June 2025 as against Rs 82.27 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales84.1182.27 2 OPM %27.1221.45 - PBDT24.3714.73 65 PBT20.1910.59 91 NP16.446.34 159 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News